|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.05 USD | -2.80% |
|
+4.69% | +36.55% |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 234M 206M 191M 176M 332M 22.41B 339M 2.28B 891M 11.01B 880M 861M 38.06B | P/E 2026 * |
-2.48x | P/E 2027 * | -3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 487M 428M 397M 365M 690M 46.6B 705M 4.73B 1.85B 22.9B 1.83B 1.79B 79.15B | EV / Sales 2026 * |
3.55x | EV / Sales 2027 * | 1.51x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -2.80% | ||
| 1 week | +4.69% | ||
| Current month | +2.87% | ||
| 1 month | +5.79% | ||
| 3 months | +25.62% | ||
| 6 months | +22.64% | ||
| Current year | +36.55% |
| 1 week | 9.29 |  | 10.86 |
| 1 month | 8.78 | | 10.86 |
| Current year | 5 | | 10.99 |
| 1 year | 3.65 | | 10.99 |
| 3 years | 3.51 | | 29.25 |
| 5 years | 3.51 | | 220.95 |
| 10 years | 3.51 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 2021-05-02 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 2025-01-02 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 2012-12-31 |
| Director/Board Member | 61 | 2013-03-31 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 2013-10-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-20 | Free | Director | 15,508 | 0.0688% | ||
| 05-20 | Free | Director | 15,508 | 0.0688% | ||
| 05-20 | Free | Director | 15,508 | 0.0688% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.80% | +4.69% | +120.88% | -59.39% | 234M | |
| -0.22% | +1.35% | +16.79% | -7.70% | 67.61B | |
| -0.63% | -9.21% | +37.82% | +200.20% | 51.6B | |
| +0.36% | +40.00% | +40.00% | +40.00% | 43B | |
| -1.26% | -0.39% | -49.63% | -53.84% | 40.94B | |
| +4.96% | -3.28% | +55.75% | -24.71% | 29.4B | |
| -1.85% | -15.99% | +99.20% | -46.78% | 27.09B | |
| -2.12% | -2.25% | +66.54% | +82.33% | 23.32B | |
| -0.67% | +1.48% | +10.61% | +188.35% | 19.92B | |
| -2.12% | -3.72% | +61.37% | +126.08% | 16.91B | |
| Average | -0.98% | -2.19% | +45.93% | +44.45% | 32B | |
| Weighted average by Cap. | -0.60% | -3.05% | +31.03% | +47.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 137M 121M 112M 103M 194M 13.12B 198M 1.33B 522M 6.45B 515M 504M 22.28B | 155M 136M 127M 116M 220M 14.85B 225M 1.51B 591M 7.3B 583M 570M 25.22B |
| Net income | -121M -106M -98.59M -90.66M -171M -11.57B -175M -1.18B -460M -5.69B -454M -444M -19.66B | -135M -118M -110M -101M -190M -12.86B -194M -1.31B -512M -6.32B -505M -494M -21.85B |
| Net Debt | 253M 222M 206M 190M 358M 24.19B 366M 2.46B 962M 11.89B 950M 929M 41.09B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | US$10.05 | -2.80% | 420,894 |
| 26-07-10 | US$10.34 | +1.37% | 320,246 |
| 26-07-09 | US$10.20 | -4.40% | 281,109 |
| 26-07-08 | US$10.67 | +6.17% | 737,365 |
| 26-07-07 | US$10.05 | +4.47% | 249,660 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
